RAGE Biotech
PrivateLast Round
Series A
Nov 13, 2025
Total Funding Raised
$24.17M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RAGE Biotech is a biotechnology company developing novel therapeutics targeting the Receptor for Advanced Glycation End-products (RAGE) for patients with difficult-to-treat inflammatory disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RAGE Biotech Comparables
Compare RAGE Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cantex Pharmaceuticals | 77% | |
| Arrowhead Pharmaceuticals | 76% | |
| Ethris | 72% | |
RAGE Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 13, 2025 | ||||
| Grant | Sep 4, 2025 | ||||
| Grant | Sep 4, 2024 | ||||
| Accelerator | Apr 18, 2024 | ||||
| Grant | Dec 21, 2022 | ||||
Grant | Jul 19, 2022 |
RAGE Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IP Group | Seed |
| CUREator | Grant |
| Hostplus Superannuation Fund | Series A |
| IP Group Australia | Series A |
| mRNA Victoria | Grant |
| Monash Investment Holdings | Seed, Series A |
| Jumar Bioincubator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2025
$21M round completed.
RAGE Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RAGE Biotech's valuation, stock price, and market status.